申请人:Ciba-Geigy Corporation
公开号:US04497813A1
公开(公告)日:1985-02-05
Derivatives of 3-aminopropane-1,2-diol of the formula ##STR1## in which Ar represents optionally substituted aryl, n represents the number 0 or 1, and alk represents alkylene having 2 to 5 carbon atoms, the nitrogen atom and the oxygen atom, or, if n is zero, the phenyl radical, being separated from one another by at least two carbon atoms, and R.sub.1 and R.sub.2, independently of one another, each represents hydrogen or lower alkyl, or together they represent lower alkylene, oxa-lower alkylene, thia-lower alkylene, aza-lower alkylene or N-lower alkyl-aza-lower alkylene, and salts of such compounds, processes for their manufacture, medicaments containing the new compounds and their use for the treatment of Angina pectoris and cardiac arrhythmia, and as blood pressure-reducing agents, as well as for the treatment of reactive or endogenic states of depression.
3-氨基丙烷-1,2-二醇的衍生物的化学式为##STR1##其中Ar代表可选择取代的芳基,n代表数字0或1,alk代表具有2至5个碳原子的烷基,氮原子和氧原子,或者如果n为零,则苯基与彼此至少相隔两个碳原子,而R.sub.1和R.sub.2,彼此独立地,每个代表氢或较低的烷基,或者它们一起代表较低的烷基,氧杂环较低的烷基,硫杂环较低的烷基,氮杂环较低的烷基或N-较低烷基-氮杂环较低的烷基,以及这类化合物的盐,其制备方法,含有新化合物的药物以及它们用于治疗心绞痛和心律失常,以及作为降血压剂,以及用于治疗反应性或内源性抑郁状态。